Home Clinical Topics U.S. Food and Drug Administration (FA) approved Voraxaze (glucarpidase)

U.S. Food and Drug Administration (FA) approved Voraxaze (glucarpidase)

On Jan. 17, the U.S. Food and Drug Administration (FA) approved Voraxaze (glucarpidase) to treat patients with toxic blood levels of methotrexate because of renal failure. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here